Bolt Biotherapeutics Stock Forecast

BOLT's stock price has decreased by -53.45% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 3 professional analysts, the 12-month price target for Bolt Biotherapeutics stock ranges from a low of $7.00 to a high of $75. The average analyst price target of $34 forecasts a 527.31% increase in the stock price over the next year.

Price Target: $34.00 (+527.31%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$7.00	$34	$20	$75
Change	+29.15%	+527.31%	+269.00%	+1283.8%

* Price targets were last updated on Oct 20, 2025.

Analyst Ratings

The average analyst rating for Bolt Biotherapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25
Strong Buy	1	1	1	2	2	2
Buy	0	0	0	0	0	0
Hold	2	2	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	3	4	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Robert Burns HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Initiates $7	Strong Buy	Initiates	$7	+29.15%	Oct 20, 2025
Chad Messer Lake Street	Lake Street	Strong Buy Maintains $4 → $75	Strong Buy	Maintains	$4 → $75	+1,283.76%	Aug 15, 2025
Chad Messer Lake Street	Lake Street	Strong Buy Initiates $80	Strong Buy	Initiates	$80	+1,376.01%	May 20, 2025
Stephen Willey Stifel	Stifel	Hold Maintains $25 → $20	Hold	Maintains	$25 → $20	+269.00%	May 13, 2025
Edward White HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Mar 25, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

6.32M

from 7.69M

-17.80%

from 7.69M

Revenue Next Year

3.57M

from 6.32M

-43.52%

from 6.32M

EPS This Year

-19.16

from -33.06

EPS Next Year

-12.76

from -19.16

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	231.00K	1.26M	5.73M	7.88M	7.69M	6.32M	3.57M
Revenue Growth	7.44%	445.46%	354.68%	37.48%	-2.36%	-17.80%	-43.52%
EPS	-577.72	-59.40	-47.16	-36.60	-33.06	-19.16	-12.76
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	7	7

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	7.0M	6.3M
Avg	6.3M	3.6M
Low	5.6M	980,000

Revenue Growth

Revenue Growth	2025	2026
High	-8.6%	-0.3%
Avg	-17.8%	-43.5%
Low	-27.4%	-84.5%

EPS Forecast

EPS	2025	2026
High	-19.72	-12.63
Avg	-19.16	-12.76
Low	-18.40	-12.72

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.